Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Change in Acquisitions & Divestments: 2020-2024

Historic Change in Acquisitions & Divestments for Therapeutics (RAPT) over the last 5 years, with Dec 2024 value amounting to $135.0 million.

  • Therapeutics' Change in Acquisitions & Divestments fell 60.56% to $30.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $135.0 million, marking a year-over-year decrease of 49.38%. This contributed to the annual value of $135.0 million for FY2024, which is 49.38% down from last year.
  • Therapeutics' Change in Acquisitions & Divestments amounted to $135.0 million in FY2024, which was down 49.38% from $266.8 million recorded in FY2023.
  • Therapeutics' 5-year Change in Acquisitions & Divestments high stood at $266.8 million for FY2023, and its period low was $52.3 million during FY2020.
  • In the last 3 years, Therapeutics' Change in Acquisitions & Divestments had a median value of $146.2 million in 2022 and averaged $182.7 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first surged by 82.45% in 2023, then crashed by 49.38% in 2024.
  • Yearly analysis of 5 years shows Therapeutics' Change in Acquisitions & Divestments stood at $52.3 million in 2020, then surged by 61.36% to $84.4 million in 2021, then surged by 73.27% to $146.2 million in 2022, then spiked by 82.45% to $266.8 million in 2023, then plummeted by 49.38% to $135.0 million in 2024.